Clinical Trials Directory

Trials / Completed

CompletedNCT05015114

Prevalence and Factors of Sarcopenia and in Patients With Primary Sjogren's Syndrome

Prevalence and Factors of Sarcopenia in Patients With Primary Sjogren's Syndrome

Status
Completed
Phase
Study type
Observational
Enrollment
50 (actual)
Sponsor
Acibadem University · Academic / Other
Sex
All
Age
40 Years – 70 Years
Healthy volunteers

Summary

Sarcopenia is a progressive condition characterized by decline in muscle strength and muscle mass. Although the mechanism of sarcopenia has not been fully elucidated, it may be caused by protein-poor diet, vitamin D deficiency, hormonal changes, increase in inflammatory cytokine level and oxidative stress. For this reason, it is thought that determining the prevalence of sarcopenia in rheumatological diseases with chronic inflammation and protecting patients from possible comorbidities with appropriate interventions may be an important factor in maintaining and improving the functional levels and quality of life of patients. The aim of our study was to investigate the prevalence and its associated factors of sarcopenia in individuals with primary Sjögren's Syndrome.

Conditions

Interventions

TypeNameDescription
OTHERSarcopenia AssessmentSarcopenia Assessment

Timeline

Start date
2021-08-12
Primary completion
2022-05-05
Completion
2022-05-05
First posted
2021-08-20
Last updated
2022-05-25

Locations

1 site across 1 country: Turkey (Türkiye)

Source: ClinicalTrials.gov record NCT05015114. Inclusion in this directory is not an endorsement.